Zions Bancorporation, N.A. Eli Lilly & CO Transaction History

Zions Bancorporation, N.A.

$1.36 Billion
Q3 2024

A detailed history of Zions Bancorporation, N.A. transactions in Eli Lilly & CO stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 9,330 shares of LLY stock, worth $7.16 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

9,330

Previous 8,326 12.06%

Holding current value

$7.16 Million

Previous $7.54 Million 9.64%

% of portfolio

0.61%

Previous 0.61%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$772.14 - $960.02 $775,228 - $963,860	1,004 Added 12.06%	9,330 $8.27 Million
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $1.39 Million - $1.75 Million	-1,924 Reduced 18.77%	8,326 $7.54 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $670,962 - $897,653	1,133 Added 12.43%	10,250 $7.97 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $126,570 - $149,210	241 Added 2.72%	9,117 $5.31 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $273,861 - $377,559	630 Added 7.64%	8,876 $4.77 Million
Q2 2023 Jul 28, 2023	SELL	$350.74 - $468.98 $50,506 - $67,533	-144 Reduced 1.72%	8,246 $3.87 Million
Q1 2023 May 10, 2023	BUY	$310.63 - $364.82 $989,356 - $1.16 Million	3,185 Added 61.19%	8,390 $2.88 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $47,267 - $55,076	147 Added 2.91%	5,205 $1.9 Million
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $6,819 - $7,771	23 Added 0.46%	5,058 $1.64 Million
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $191,487 - $224,834	-687 Reduced 12.01%	5,035 $1.63 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $280,923 - $349,117	-1,197 Reduced 17.3%	5,722 $1.64 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $111,975 - $138,961	498 Added 7.76%	6,919 $1.91 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $131,852 - $162,262	595 Added 10.21%	6,421 $1.48 Million
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $363,808 - $470,583	2,015 Added 52.87%	5,826 $1.34 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $63,920 - $82,748	389 Added 11.37%	3,811 $712,000
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $2,087 - $2,762	-16 Reduced 0.47%	3,422 $578,000
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $4,679 - $5,412	-32 Reduced 0.92%	3,438 $509,000
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $117,866 - $141,851	864 Added 33.15%	3,470 $570,000
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $180,241 - $223,087	1,514 Added 138.64%	2,606 $362,000
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $11,654 - $14,434	-109 Reduced 9.08%	1,092 $144,000
Q2 2019 Jul 09, 2019	SELL	$110.79 - $129.32 $243,184 - $283,857	-2,195 Reduced 64.63%	1,201 $133,000
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $378,008 - $444,943	3,396 New	3,396 $441,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.

Account

Zions Bancorporation, N.A. Eli Lilly & CO Transaction History